RxDoctor Payments DataLook up a doctor →

Iris Gutmark-Little

Pediatric Endocrinology · Cincinnati, OHNPI 1811193337

Payments from drug & device makers

$640,983in general payments, 2019–2025

Across 1,226 payments — averaging $522.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$264K
  • Ascendis Pharma Endocrinology Inc$142K
  • OPKO Pharmaceuticals, LLC$102K
  • Ipsen Pharma SAS$94K
  • Pfizer$32K
  • Biomarin Pharmaceutical Inc.$6K
  • plus $694 from 3 others
$4,453in research payments, 2019–2025

Across 10 payments — averaging $445.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$2K
  • Novo Nordisk$2K
  • Sanofi$500

What the payments were for

  • Speaking & faculty fees$9,66270%
  • Travel & lodging$2,42018%
  • Food & beverage$1,60112%
  • Education$320%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$640,983 in reported general payments places this provider in the 95th percentile of 76 pediatric endocrinology providers in Ohio.

See all pediatric endocrinology providers in Ohio

Other pediatric endocrinology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →